Form 8K icad inc For: 17 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
icad inc (ICAD)
icad inc stock price live, this page displays NASDAQ ICAD stock exchange data. View the ICAD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the icad inc real time stock price chart below.
What Is the icad inc Stock Price Today?
The icad inc stock price today is 3.870.
What Is the Stock Symbol for icad inc?
The stock symbol for icad inc is ""ICAD.""
What Stock Exchange Does icad inc Trade On?
icad inc is listed and trades on the NASDAQ stock exchange.
Is icad inc a Good Stock to Buy?
Determining whether icad inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ICAD quote. (ISIN: US44934S2068)
What Is the icad inc Stock Price Today?
The icad inc stock price today is 3.870.
What Is the Stock Symbol for icad inc?
The stock symbol for icad inc is ""ICAD.""
What Stock Exchange Does icad inc Trade On?
icad inc is listed and trades on the NASDAQ stock exchange.
Is icad inc a Good Stock to Buy?
Determining whether icad inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ICAD quote. (ISIN: US44934S2068)
NASDAQ
Currency in USD
3.870
+0.140(+3.75%)
Closed·
Fair Value
An estimate of a icad's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.710
3.880
52 wk Range
1.190
4.015
Showing icad historical data. For real-time data please try another search
Fair Value
An estimate of a icad's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.7103.880
52 wk Range
1.1904.015
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ICAD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a icad's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Currently not supported.
- RadNet’s DeepHealth subsidiary completes iCAD acquisition
- Investing.com
Pro - Proxy advisors back RadNet’s acquisition of iCAD
- Investing.com
- Form 8K icad inc For: 17 July
- Investing.com
- RadNet’s DeepHealth subsidiary completes iCAD acquisition
- Investing.com
Pro - Proxy advisors back RadNet’s acquisition of iCAD
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
icad inc Company Profile
iCAD, Inc. provides AI-powered cancer detection solutions in the United States. The company’s ProFound Breast Health Suite offers solutions for breast cancer detection, breast density assessment, one- or two-year breast cancer risk evaluation, and cardiovascular risk assessment related to elevated levels of breast arterial calcifications; and enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Detection solutions include advanced artificial intelligence and image analysis workflow solutions to identifying pathologies and pinpointing prevalent cancers earlier; and a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging, and computed tomography. In addition, the company suite offers solutions for cancer detection, density assessment, and personalized risk evaluation based on a 2D or 3D mammogram’s collection of images. Additionally, its density assessment standardizes and simplifies breast density reporting by algorithmically examining a woman’s breast anatomy from the mammogram image. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. As of July 17, 2025, iCAD, Inc. operates as a subsidiary of DeepHealth, Inc.
icad inc Earnings Call Summary for Q4/2024
- iCAD Q4 2024 EPS of -$0.03 beat -$0.06 forecast; revenue of $5.41M exceeded $4.5M expectation; stock surged 13.36% after hours
- Revenue up 14% YoY to $5.4M; full-year product revenue increased 26% to $12.5M as company transitions to SaaS model
- Gross profit margin decreased to 86% from 91% YoY; cash and equivalents at $17.2M as of Dec 31, 2024
- CEO expects significant growth in cloud deals for 2025, enhancing financial predictability; company to report additional backlog metrics
- Transition to SaaS model may impact near-term revenue recognition; decreased gross margin and ongoing cash usage pose challenges
Last Updated: 19/03/2025, 22:34
Read Full TranscriptCompare ICAD to Peers and Sector
Metrics to compare | ICAD | Peers Peers - average of corresponding metrics from companies closely matching ICAD: | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipICADPeersSector |
|---|---|---|---|---|
P/E Ratio | −20.2x | 0.0x | −0.5x | |
PEG Ratio | 0.16 | 0.00 | 0.00 | |
Price/Book | 3.4x | 0.0x | 2.6x | |
Price / LTM Sales | 5.4x | 0.0x | 3.3x | |
Upside (Analyst Target) | −3.1% | 0.0% | 42.9% | |
Fair Value Upside | Unlock | 0.0% | 6.2% | Unlock |
Earnings
Latest Release
Aug 06, 2025
EPS / Forecast
-- / -0.055
Revenue / Forecast
-- / 4.81M
People Also Watch
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.